Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis-Reference-Cited by-同舟云学术

Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis

Published:2021-11-13 Issue: Volume: Page:
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Marston Nicholas A.¹,Giugliano Robert P.¹,Melloni Giorgio E. M.¹,Park Jeong-Gun¹,Morrill Valerie²,Blazing Michael A.³,Ference Brian⁴,Stein Evan⁵,Stroes Erik S.⁶,Braunwald Eugene¹,Ellinor Patrick T.²⁷⁸,Lubitz Steven A.²⁷⁸,Ruff Christian T.¹,Sabatine Marc S.¹

Affiliation:

1. Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. Cardiovascular Disease Initiative, The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts

3. Department of Medicine, Duke University, Durham, North Carolina

4. University of Cambridge, Cambridge, United Kingdom

5. Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio

6. University Medical Center Amsterdam, Amsterdam, the Netherlands

7. Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston

8. Demoulas Center for Cardiac Arrythmias, Massachusetts General Hospital, Harvard Medical School, Boston

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2786333/jamacardiology_marston_2021_oi_210083_1636592851.61026.pdf

Reference22 articles.

1. Factors of risk in the development of coronary heart disease—six year follow-up experience. the Framingham Study.;Kannel;Ann Intern Med,1961

2. Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease.;Castañer;J Am Coll Cardiol,2020

3. VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins.;Balling;J Am Coll Cardiol,2020

4. Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease.;Ference;JAMA,2019

5. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable mendelian randomisation analysis.;Richardson;PLoS Med,2020

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of serum apolipoproteins on the prognosis of acute ischemic stroke after thrombolysis;Journal of Stroke and Cerebrovascular Diseases;2024-11

2. Does flaxseed supplementation affect apo-lipoproteins? A GRADE-assessed systematic review and meta-analysis;Prostaglandins & Other Lipid Mediators;2024-10

3. Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study;Diabetes, Obesity and Metabolism;2024-09-10

4. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus from the national lipid association;Journal of Clinical Lipidology;2024-09

5. Monoclonal Anti-PCSK9 Antibodies: Real-World Data;Journal of Clinical Medicine;2024-08-03